HSCS
NASDAQ HealthcareHeartSciences Inc. - Common Stock
Medical Devices
HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
�� 市场数据
| 价格 | $5.20 |
|---|---|
| 成交量 | 174,295 |
| 市值 | 24.96M |
| RSI（14日） | 74.1 超买 |
| 200日均线 | $2.57 |
| 50日均线 | $2.74 |
| 52周最高 | $5.21 |
| 52周最低 | $1.63 |
| Forward P/E | -2.97 |
| Price / Book | 73.24 |
🎯 投资策略评分
HSCS 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🎈 Over-Hyped (97/100) — 此策略 超买股票（潜在做空标的）.
评分最低的策略： 🚀 Moon Shot (1/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 HSCS in your text
粘贴任何文章、记录或帖子 — 工具将提取 HSCS 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-09-18.